Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku gynecologic cancer unit 101 group study)

Tadahiro Shoji, Eriko Takatori, Hideo Omi, Seisuke Kumagai, Akira Yoshizaki, Yoshihito Yokoyama, Hideki Mizunuma, Toshio Fujimoto, Tadao Takano, Nobuo Yaegashi, Toru Tase, Kenji Nakahara, Hirohisa Kurachi, Hiroshi Nishiyama, Toru Sugiyama

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku gynecologic cancer unit 101 group study)'. Together they form a unique fingerprint.

Medicine & Life Sciences